Citations

Clear

5212 citation(s) found for "Wang, Li-Ju".

Role of Endoscopic vs Percutaneous Biliary Drainage in the Treatment of Malignant Biliary Tract Obstruction
Jia, Zhongzhi , Sella, David M., Wang, Weiping

Mayo Clinic

JAMA Oncology | April 14, 2016 | Volume: 2 | Issue: 4 | Pages: 547

10.1001/jamaoncol.2015.6106 | PMID 27077900 Get It

Target-enrichment sequencing and copy number evaluation in inherited polyneuropathy
Wang, Wei , Dawson, D. Brian, Thorland, Erik C., Lundquist, Patrick A. , Eckloff, Bruce W., Baheti, Saurabh , Evans, Jared M., Scherer, Steven S. , Dyck, P. James B. , Klein, Christopher J. , Wang, Chen , Wu, Yanhong , Klein, Christopher J

Mayo Clinic

Neurology | April 14, 2016 | Volume: 86 | Issue: 19 | Pages: 1762-1771

10.1212/wnl.0000000000002659 | PMID 27164712 Get It

Clinical activity of carfilzomib correlates with inhibition of multiple proteasome subunits: application of a novel pharmacodynamic assay
Levitsky, Konstantin, Parlati, Francesco , Bennett, Mark K. , Arastu‐Kapur, Shirin, Kellerman, Lois, Woo, Tina F., Papadopoulos, Kyriakos P. , Niesvizky, Rubén, Badros, Ashraf , Vij, Ravi , Wang, Michael , Ahmann, Gregory , Kirk, Christopher J., Ahmann, Gregory J, Lee, Sang Hyuck , Wong, Alvin , Jagannath, Sundar , Siegel, David S.

Mayo Clinic

British Journal of Haematology | April 13, 2016 | Volume: 173 | Issue: 6 | Pages: 884-895

10.1111/bjh.14014 | PMID 27071340 Get It

SummaryWhile proteasome inhibition is a validated therapeutic approach for multiple myeloma (MM), inhibition of individual constitutive proteasome (c20S) and immunoproteasome (i20S) subunits has not been fully explored owing to a lack of effective tools. We utilized the novel proteasome constitutive/immunoproteasome subunit enzyme‐linked immunosorbent (ProCISE) assay to quantify proteasome subunit occupancy in samples from five phase I/II and II trials before and after treatment with the proteasome inhibitor carfilzomib. Following the first carfilzomib dose (15–56 mg/m2), dose‐dependent inhibition of c20S and i20S chymotrypsin‐like active sites was observed [whole blood: ≥67%; peripheral blood mononuclear cells (PBMCs): ≥75%]. A similar inhibition profile was observed in bone marrow–derived CD138+ tumour cells. Carfilzomib‐induced proteasome inhibition was durable, with minimal recovery in PBMCs after 24 h but near‐complete recovery between cycles. Importantly, the ProCISE assay can be used to quantify occupancy of individual c20S and i20S subunits. We observed a relationship between MM patient response (n = 29), carfilzomib dose and occupancy of multiple i20S subunits, where greater occupancy was associated with an increased likelihood of achieving a clinical response at higher doses. ProCISE represents a new tool for measuring proteasome inhibitor activity in clinical trials and relating drug action to patient outcomes.
BLM promotes the activation of Fanconi Anemia signaling pathway
Panneerselvam, Jayabal, Che, Raymond , Fei, Peiwen, Wang, Hong , Zhang, Jun , Yu, Kai

Mayo Clinic

Oncotarget | April 12, 2016 | Volume: 7 | Issue: 22 | Pages: 32351-32361

10.18632/oncotarget.8707 | PMID 27083049 Get It

Tissue interactions, cell signaling and transcriptional control in the cranial mesoderm during craniofacial development
Fan, Xiaochen , Loebel, David A.F., Bildsoe, Heidi , Wilkie, Emilie , Wang, Junwen , Qin, Jing , Tam, Patrick , Wang, Junwen

Mayo Clinic

AIMS Genetics | April 12, 2016 | Volume: 03 | Issue: 01 | Pages: 074-098

10.3934/genet.2016.1.74 Get It

AbstractThe cranial neural crest and the cranial mesoderm are the source of tissues from which the bone and cartilage of the skull, face and jaws are constructed. The development of the cranial mesoderm is not well studied, which is inconsistent with its importance in craniofacial morphogenesis as a source of precursor tissue of the chondrocranium, muscles, vasculature and connective tissues, mechanical support for tissue morphogenesis, and the signaling activity that mediate interactions with the cranial neural crest. Phenotypic analysis of conditional knockout mouse mutants, complemented by the transcriptome analysis of differentially enriched genes in the cranial mesoderm and cranial neural crest, have identified signaling pathways that may mediate cross-talk between the two tissues. In the cranial mesenchyme, Bmp4 is expressed in the mesoderm cells while its signaling activity could impact on both the mesoderm and the neural crest cells. In contrast, Fgf8 is predominantly expressed in the cranial neural crest cells and it influences skeletal development and myogenesis in the cranial mesoderm. WNT signaling, which emanates from the cranial neural crest cells, interacts with BMP and FGF signaling in monitoring the switch between tissue progenitor expansion and differentiation. The transcription factor Twist1, a critical molecular regulator of many aspects of craniofacial development, coordinates the activity of the above pathways in cranial mesoderm and cranial neural crest tissue compartments.
Improved perioperative analgesia with ultrasound-guided ilioinguinal/iliohypogastric nerve or transversus abdominis plane block for open inguinal surgery: a systematic review and meta-analysis of randomized controlled trials
Terry, Marisa J., Eldrige, Jason S. , Tong, Qiang , Erwin, Patricia J., Qu, Wenchun , Wang, Yuexiang, Wang, Yuexiang , Wu, Tao , Tong, Qiang, Wang, Zhen

Mayo Clinic

Journal of Physical Therapy Science | March 30, 2016 | Volume: 28 | Issue: 3 | Pages: 1055-1060

10.1589/jpts.28.1055 | PMID 27134411 Get It

FOXA1 defines cancer cell specificity
Zhang, Gaihua , Zhao, Yongbing , Kao, Li-Pin, Skerry, Benjamin, Li, Zhaoyu , Li, Zhaoyu , Liu, Yi Sha , Wang, Xiao

Mayo Clinic

Science Advances | March 19, 2016 | Volume: 2 | Issue: 3 | Pages: No page available

10.1126/sciadv.1501473 | PMID 27034986 Get It

Functional FOXA1 targeting is mostly unique to each of the four human cancer cell lines HepG2, LNCaP, MCF7, and T47D.
Linkage and related analyses of Barrett's esophagus and its associated adenocarcinomas
Sun, Xiangqing , Elston, Robert C. , Faulx, Ashley L., Shaheen, Nicholas J. , Wang, Jean S. , Iyer, Prasad G. , Guda, Kishore , Markowitz, Sanford D. , Barnholtz‐Sloan, Jill S. , Chandar, Apoorva K., Brock, Wendy , Chak, Amitabh , Falk, Gary W. , Grady, William M. , Mittal, Sumeet K. , Canto, Marcia Irene , Abrams, Julian A , Willis, Joseph , Barnholtz-Sloan, Jill S

Mayo Clinic

Molecular Genetics & Genomic Medicine | March 19, 2016 | Volume: 4 | Issue: 4 | Pages: 407-419

10.1002/mgg3.211 | PMID 27468417 Get It

AbstractBackgroundFamilial aggregation and segregation analysis studies have provided evidence of a genetic basis for esophageal adenocarcinoma (EAC) and its premalignant precursor, Barrett's esophagus (BE). We aim to demonstrate the utility of linkage analysis to identify the genomic regions that might contain the genetic variants that predispose individuals to this complex trait (BE and EAC).MethodsWe genotyped 144 individuals in 42 multiplex pedigrees chosen from 1000 singly ascertained BE/EAC pedigrees, and performed both model‐based and model‐free linkage analyses, using S.A.G.E. and other software. Segregation models were fitted, from the data on both the 42 pedigrees and the 1000 pedigrees, to determine parameters for performing model‐based linkage analysis. Model‐based and model‐free linkage analyses were conducted in two sets of pedigrees: the 42 pedigrees and a subset of 18 pedigrees with female affected members that are expected to be more genetically homogeneous. Genome‐wide associations were also tested in these families.ResultsLinkage analyses on the 42 pedigrees identified several regions consistently suggestive of linkage by different linkage analysis methods on chromosomes 2q31, 12q23, and 4p14. A linkage on 15q26 is the only consistent linkage region identified in the 18 female‐affected pedigrees, in which the linkage signal is higher than in the 42 pedigrees. Other tentative linkage signals are also reported.ConclusionOur linkage study of BE/EAC pedigrees identified linkage regions on chromosomes 2, 4, 12, and 15, with some reported associations located within our linkage peaks. Our linkage results can help prioritize association tests to delineate the genetic determinants underlying susceptibility to BE and EAC.
Assessment of Multifactor Gene–Environment Interactions and Ovarian Cancer Risk: Candidate Genes, Obesity, and Hormone-Related Risk Factors
Usset, Joseph , McGuire, Valerie , Sieh, Weiva , Webb, Penelope M. , Chang‐Claude, Jenny, Brinton, Louise A. , Cunningham, Julie M. , DeFazio, Anna , Edwards, Robert P., Gayther, Simon A. , Goodman, Marc T. , Høgdall, Estrid , Jensen, Allan , Johnatty, Sharon E., Lurie, Galina, Massuger, Leon F.A.G. , Menon, Usha , Moysich, Kirsten B. , Ness, Roberta B., Pike, Malcolm C. , Ramus, Susan J. , Rossing, Mary Anne, Rothstein, Joseph H. , Song, Honglin , Thompson, Pamela J., Berg, David J. Van Den, Vierkant, Robert A. , Wang‐Gohrke, Shan , Wentzensen, Nicolas , Whittemore, Alice S. , Wu, Anna H. , Pearce, Celeste Leigh, Schildkraut, Joellen M. , Goode, Ellen L. , Fazio, Anna de , Raghavan, Rama , Tyrer, Jonathan P. , Rudolph, Anja , Anton‐Culver, Hoda , Berchuck, Andrew , Doherty, Jennifer A. , Gentry‐Maharaj, Aleksandra , Kiemeney, Lambertus A. , Kjær, Susanne K. , Larson, Melissa C. , Modugno, Francesmary , Wilkens, Lynne R. , Yang, Hannah , Pharoah, Paul D.P. , Fridley, Brooke L. , Ramus, Susan J , Webb, Penelope M , Jensen, Allan , Vierkant, Robert A , Menon, Usha , Moysich, Kirsten , Sieh, Weiva , Høgdall, Estrid , Goodman, Marc T

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | March 14, 2016 | Volume: 25 | Issue: 5 | Pages: 780-790

10.1158/1055-9965.epi-15-1039 | PMID 26976855 Get It

Abstract Background: Many epithelial ovarian cancer (EOC) risk factors relate to hormone exposure and elevated estrogen levels are associated with obesity in postmenopausal women. Therefore, we hypothesized that gene–environment interactions related to hormone-related risk factors could differ between obese and non-obese women. Methods: We considered interactions between 11,441 SNPs within 80 candidate genes related to hormone biosynthesis and metabolism and insulin-like growth factors with six hormone-related factors (oral contraceptive use, parity, endometriosis, tubal ligation, hormone replacement therapy, and estrogen use) and assessed whether these interactions differed between obese and non-obese women. Interactions were assessed using logistic regression models and data from 14 case–control studies (6,247 cases; 10,379 controls). Histotype-specific analyses were also completed. Results: SNPs in the following candidate genes showed notable interaction: IGF1R (rs41497346, estrogen plus progesterone hormone therapy, histology = all, P = 4.9 × 10−6) and ESR1 (rs12661437, endometriosis, histology = all, P = 1.5 × 10−5). The most notable obesity–gene–hormone risk factor interaction was within INSR (rs113759408, parity, histology = endometrioid, P = 8.8 × 10−6). Conclusions: We have demonstrated the feasibility of assessing multifactor interactions in large genetic epidemiology studies. Follow-up studies are necessary to assess the robustness of our findings for ESR1, CYP11A1, IGF1R, CYP11B1, INSR, and IGFBP2. Future work is needed to develop powerful statistical methods able to detect these complex interactions. Impact: Assessment of multifactor interaction is feasible, and, here, suggests that the relationship between genetic variants within candidate genes and hormone-related risk factors may vary EOC susceptibility. Cancer Epidemiol Biomarkers Prev; 25(5); 780–90. ©2016 AACR.
Deregulated methionine adenosyltransferase α1, c‐Myc, and Maf proteins together promote cholangiocarcinoma growth in mice and humans‡
Yang, Heping , Liu, Ting , Wang, Jiaohong, Li, Tony W.H., Fan, Wei , Peng, Hui , Krishnan, Anuradha , Mato, José M. , Lu, Shelly C. , Gores, Gregory J. , Lu, Shelly C.

Mayo Clinic

Hepatology | March 12, 2016 | Volume: 64 | Issue: 2 | Pages: 439-455

10.1002/hep.28541 | PMID 26969892 Get It

c‐Myc induction drives cholestatic liver injury and cholangiocarcinoma (CCA) in mice, and induction of Maf proteins (MafG and c‐Maf) contributes to cholestatic liver injury, whereas S‐adenosylmethionine (SAMe) administration is protective. Here, we determined whether there is interplay between c‐Myc, Maf proteins, and methionine adenosyltransferase α1 (MATα1), which is responsible for SAMe biosynthesis in the liver. We used bile duct ligation (BDL) and lithocholic acid (LCA) treatment in mice as chronic cholestasis models, a murine CCA model, human CCA cell lines KMCH and Huh‐28, human liver cancer HepG2, and human CCA specimens to study gene and protein expression, protein‐protein interactions, molecular mechanisms, and functional outcomes. We found that c‐Myc, MATα1 (encoded by MAT1A), MafG, and c‐Maf interact with one another directly. MAT1A expression fell in hepatocytes and bile duct epithelial cells during chronic cholestasis and in murine and human CCA. The opposite occurred with c‐Myc, MafG, and c‐Maf expression. MATα1 interacts mainly with Mnt in normal liver, but this switches to c‐Maf, MafG, and c‐Myc in cholestatic livers and CCA. Promoter regions of these genes have E‐boxes that are bound by MATα1 and Mnt in normal liver and benign bile duct epithelial cells that switched to c‐Myc, c‐Maf, and MafG in cholestasis and CCA cells. E‐box positively regulates c‐Myc, MafG, and c‐Maf, but it negatively regulates MAT1A. MATα1 represses, whereas c‐Myc, MafG, and c‐Maf enhance, E‐box‐driven promoter activity. Knocking down MAT1A or overexpressing MafG or c‐Maf enhanced CCA growth and invasion in vivo. Conclusion: There is a novel interplay between MATα1, c‐Myc, and Maf proteins, and their deregulation during chronic cholestasis may facilitate CCA oncogenesis. (Hepatology 2016;64:439‐455)